Index
1 Market Overview
1.1 Product Overview and Scope of Intramuscular HPV Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intramuscular HPV Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Bivalent
1.3.3 Quadrivalent
1.3.4 Nine-valent
1.4 Market Analysis by Application
1.4.1 Overview: Global Intramuscular HPV Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Male
1.4.3 Female
1.5 Global Intramuscular HPV Vaccine Market Size & Forecast
1.5.1 Global Intramuscular HPV Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Intramuscular HPV Vaccine Sales Quantity (2018-2029)
1.5.3 Global Intramuscular HPV Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck Sharp & Dohme (MSD)
2.1.1 Merck Sharp & Dohme (MSD) Details
2.1.2 Merck Sharp & Dohme (MSD) Major Business
2.1.3 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Product and Services
2.1.4 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Sharp & Dohme (MSD) Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Intramuscular HPV Vaccine Product and Services
2.2.4 Pfizer Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Intramuscular HPV Vaccine Product and Services
2.3.4 Sanofi Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Intramuscular HPV Vaccine Product and Services
2.4.4 GSK Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GSK Recent Developments/Updates
2.5 Serum Institute
2.5.1 Serum Institute Details
2.5.2 Serum Institute Major Business
2.5.3 Serum Institute Intramuscular HPV Vaccine Product and Services
2.5.4 Serum Institute Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Serum Institute Recent Developments/Updates
2.6 Astellas Pharma
2.6.1 Astellas Pharma Details
2.6.2 Astellas Pharma Major Business
2.6.3 Astellas Pharma Intramuscular HPV Vaccine Product and Services
2.6.4 Astellas Pharma Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Astellas Pharma Recent Developments/Updates
2.7 CSL
2.7.1 CSL Details
2.7.2 CSL Major Business
2.7.3 CSL Intramuscular HPV Vaccine Product and Services
2.7.4 CSL Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CSL Recent Developments/Updates
2.8 Emergent BioSolutions
2.8.1 Emergent BioSolutions Details
2.8.2 Emergent BioSolutions Major Business
2.8.3 Emergent BioSolutions Intramuscular HPV Vaccine Product and Services
2.8.4 Emergent BioSolutions Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Emergent BioSolutions Recent Developments/Updates
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business
2.9.3 GlaxoSmithKline Intramuscular HPV Vaccine Product and Services
2.9.4 GlaxoSmithKline Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GlaxoSmithKline Recent Developments/Updates
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Intramuscular HPV Vaccine Product and Services
2.10.4 Johnson & Johnson Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Johnson & Johnson Recent Developments/Updates
2.11 MedImmune
2.11.1 MedImmune Details
2.11.2 MedImmune Major Business
2.11.3 MedImmune Intramuscular HPV Vaccine Product and Services
2.11.4 MedImmune Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 MedImmune Recent Developments/Updates
2.12 Walvax Biotechnology
2.12.1 Walvax Biotechnology Details
2.12.2 Walvax Biotechnology Major Business
2.12.3 Walvax Biotechnology Intramuscular HPV Vaccine Product and Services
2.12.4 Walvax Biotechnology Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Walvax Biotechnology Recent Developments/Updates
2.13 Liaoning Chengda Biotechnology
2.13.1 Liaoning Chengda Biotechnology Details
2.13.2 Liaoning Chengda Biotechnology Major Business
2.13.3 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Product and Services
2.13.4 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Liaoning Chengda Biotechnology Recent Developments/Updates
2.14 Hualan Biological Engineering
2.14.1 Hualan Biological Engineering Details
2.14.2 Hualan Biological Engineering Major Business
2.14.3 Hualan Biological Engineering Intramuscular HPV Vaccine Product and Services
2.14.4 Hualan Biological Engineering Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Hualan Biological Engineering Recent Developments/Updates
2.15 Sinovac Biotech
2.15.1 Sinovac Biotech Details
2.15.2 Sinovac Biotech Major Business
2.15.3 Sinovac Biotech Intramuscular HPV Vaccine Product and Services
2.15.4 Sinovac Biotech Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Sinovac Biotech Recent Developments/Updates
2.16 Chongqing Zhifei Biological Products
2.16.1 Chongqing Zhifei Biological Products Details
2.16.2 Chongqing Zhifei Biological Products Major Business
2.16.3 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Product and Services
2.16.4 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Chongqing Zhifei Biological Products Recent Developments/Updates
2.17 Chang Chun High and New Technology Industries (Group)
2.17.1 Chang Chun High and New Technology Industries (Group) Details
2.17.2 Chang Chun High and New Technology Industries (Group) Major Business
2.17.3 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Product and Services
2.17.4 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Chang Chun High and New Technology Industries (Group) Recent Developments/Updates
2.18 Beijing Wantai Biological Pharmacy Enterprise
2.18.1 Beijing Wantai Biological Pharmacy Enterprise Details
2.18.2 Beijing Wantai Biological Pharmacy Enterprise Major Business
2.18.3 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Product and Services
2.18.4 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
2.19 Jiangsu Recbio Technology
2.19.1 Jiangsu Recbio Technology Details
2.19.2 Jiangsu Recbio Technology Major Business
2.19.3 Jiangsu Recbio Technology Intramuscular HPV Vaccine Product and Services
2.19.4 Jiangsu Recbio Technology Intramuscular HPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Jiangsu Recbio Technology Recent Developments/Updates
3 Competitive Environment: Intramuscular HPV Vaccine by Manufacturer
3.1 Global Intramuscular HPV Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Intramuscular HPV Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Intramuscular HPV Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Intramuscular HPV Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Intramuscular HPV Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Intramuscular HPV Vaccine Manufacturer Market Share in 2022
3.5 Intramuscular HPV Vaccine Market: Overall Company Footprint Analysis
3.5.1 Intramuscular HPV Vaccine Market: Region Footprint
3.5.2 Intramuscular HPV Vaccine Market: Company Product Type Footprint
3.5.3 Intramuscular HPV Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Intramuscular HPV Vaccine Market Size by Region
4.1.1 Global Intramuscular HPV Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Intramuscular HPV Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Intramuscular HPV Vaccine Average Price by Region (2018-2029)
4.2 North America Intramuscular HPV Vaccine Consumption Value (2018-2029)
4.3 Europe Intramuscular HPV Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Intramuscular HPV Vaccine Consumption Value (2018-2029)
4.5 South America Intramuscular HPV Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Intramuscular HPV Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Intramuscular HPV Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Intramuscular HPV Vaccine Consumption Value by Type (2018-2029)
5.3 Global Intramuscular HPV Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Intramuscular HPV Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Intramuscular HPV Vaccine Consumption Value by Application (2018-2029)
6.3 Global Intramuscular HPV Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Intramuscular HPV Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Intramuscular HPV Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Intramuscular HPV Vaccine Market Size by Country
7.3.1 North America Intramuscular HPV Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Intramuscular HPV Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Intramuscular HPV Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Intramuscular HPV Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Intramuscular HPV Vaccine Market Size by Country
8.3.1 Europe Intramuscular HPV Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Intramuscular HPV Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Intramuscular HPV Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Intramuscular HPV Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Intramuscular HPV Vaccine Market Size by Region
9.3.1 Asia-Pacific Intramuscular HPV Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Intramuscular HPV Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Intramuscular HPV Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Intramuscular HPV Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Intramuscular HPV Vaccine Market Size by Country
10.3.1 South America Intramuscular HPV Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Intramuscular HPV Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Intramuscular HPV Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Intramuscular HPV Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Intramuscular HPV Vaccine Market Size by Country
11.3.1 Middle East & Africa Intramuscular HPV Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Intramuscular HPV Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Intramuscular HPV Vaccine Market Drivers
12.2 Intramuscular HPV Vaccine Market Restraints
12.3 Intramuscular HPV Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Intramuscular HPV Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intramuscular HPV Vaccine
13.3 Intramuscular HPV Vaccine Production Process
13.4 Intramuscular HPV Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intramuscular HPV Vaccine Typical Distributors
14.3 Intramuscular HPV Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer